NHS England Specialised Haemoglobinopathy Services
A Voluntary Ex-Ante Transparency (VEAT) Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £16M
- Sector
- HEALTH
- Published
- 01 Sep 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London
2 buyers
- NHS England London
10 suppliers
- Manchester University NHS Trust Manchester
- Sheffield Teaching Hospitals NHS Trust in Partnership with Sheffield Childrens NHS Trust Sheffield
- Leicester NHS Trust University Hospitals Leicester
- Sandwell & West Birmingham Hospitals NHS Trust & Sub Contracting to Birmingham Womens & Childrens Hospital Birmingham
- Barts Health NHS Trust London
- Kings College Hospital NHS Trust in Partnership with Guys & St Thomas NHS Trust London
- Imperial College Healthcare NHS Trust in Partnership with London North West University Healthcare NHS Trust & St Georges University Hospitals NHS Trust London
- University College London Hospitals NHS Trust in Partnership with Whittington Health NHS Trust & North Middlesex University Hospital NHS Trust London
- Oxford University Hospitals NHS Trust Oxford
- University Hospitals Bristol NHS Trust Bristol
Description
Specialised haemoglobinopathy services currently include: • 10 Haemoglobinopathy Co-ordinating Centres (HCCs) • A National Haemoglobinopathy Panel (NHP) HCCs support the network provision of specialist and non-specialist haemoglobinopathy services and to provide expert opinion and management for complex patients. The NHP supports the HCCs to provide expert advice on options for individuals with complex needs living with Sickle Cell Disease (SCD), thalassaemia or rare inherited anaemias. The NHP also supports decision making on novel treatments, improving access to interventions and clinical trials.
Lot Division
| 1 | Haemoglobinopathy Co-ordinating Centre (HCC) - North West HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 2 | Haemoglobinopathy Co-ordinating Centre (HCC) - North East and Yorkshire HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 3 | Haemoglobinopathy Co-ordinating Centre (HCC) - East Midlands HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 4 | Haemoglobinopathy Co-ordinating Centre (HCC) - West Midlands HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 5 | Haemoglobinopathy Co-ordinating Centre (HCC) - East London and Essex HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 6 | Haemoglobinopathy Co-ordinating Centre (HCC) - South East London and South East HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 7 | Haemoglobinopathy Co-ordinating Centre (HCC) - West London HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 8 | Haemoglobinopathy Co-ordinating Centre (HCC) - North Central London and East Anglia HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 9 | Haemoglobinopathy Co-ordinating Centre (HCC) - Wessex and Thames Valley HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 10 | Haemoglobinopathy Co-ordinating Centre (HCC) - South West HCCs provide a co-ordinated leadership function, supporting SHTs in the delivery of clinical care. They are responsible for coordinating, supporting and promoting a system-wide networked approach to the delivery of haemoglobinopathy services. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
| 11 | National Haemoglobinopathy Panel (NHP) The primary role of the NHP is to provide expert and evidence-based advice on the management of adults and children with sickle cell disease, thalassaemia and rare inherited anaemias, as and when requested by the clinicians caring for these patients. The anticipated contract period is 5 years with an option to extend for a further 1 year. |
Award Detail
| 1 | Manchester University NHS Trust (Manchester)
|
| 2 | Sheffield Teaching Hospitals NHS Trust in Partnership with Sheffield Childrens NHS Trust (Sheffield)
|
| 3 | Leicester NHS Trust University Hospitals (Leicester)
|
| 4 | Sandwell & West Birmingham Hospitals NHS Trust & Sub Contracting to Birmingham Womens & Childrens Hospital (Birmingham)
|
| 5 | Barts Health NHS Trust (London)
|
| 6 | Kings College Hospital NHS Trust in Partnership with Guys & St Thomas NHS Trust (London)
|
| 7 | Imperial College Healthcare NHS Trust in Partnership with London North West University Healthcare NHS Trust & St Georges University Hospitals NHS Trust (London)
|
| 8 | University College London Hospitals NHS Trust in Partnership with Whittington Health NHS Trust & North Middlesex University Hospital NHS Trust (London)
|
| 9 | Oxford University Hospitals NHS Trust (Oxford)
|
| 10 | University Hospitals Bristol NHS Trust (Bristol)
|
Renewal Options
There is an option to extend for a further 1 year following the initial 5 year period.
CPV Codes
- 85100000 - Health services
Indicators
- Options are available.
Legal Justification
The direct awards are being made under Regulation 32(2)(b)(ii) as NHS England believe that the following applies: the Services can only be supplied by a particular provider as competition is absent for technical reasons for each individual HCC geography and the NHP; there is no other reasonable alternative or substitute available for each individual HCC geography and the NHP; and NHSE has not artificially narrowed the requirement in order to ensure only the current HCCs and NHP are capable. The contract values included in this VEAT are genuine estimates. Indicative inflation has been applied for the next 6 years and averages have been included across each Lot. Exact contract value figures may differ slightly.
Reference
- FTS 025892-2023